Litcius/Paper detail

Evaluating the ability of some natural phenolic acids to target the main protease and AAK1 in SARS COV-2

Heba I. Ghamry, Amany Belal, Mohamed K. El‐Ashrey, Haytham O. Tawfik, Reem I. Alsantali, Ahmad J. Obaidullah, Ahmed A. El‐Mansi, Doaa Abdelrahman

2023Scientific Reports12 citationsDOIOpen Access PDF

Abstract

Researchers are constantly searching for drugs to combat the coronavirus pandemic caused by SARS-CoV-2, which has lasted for over two years. Natural compounds such as phenolic acids are being tested against Mpro and AAK1, which are key players in the SARS-CoV-2 life cycle. This research work aims to study the ability of a panel of natural phenolic acids to inhibit the virus's multiplication directly through Mpro and indirectly by affecting the adaptor-associated protein kinase-1 (AAK1). Pharmacophore mapping, molecular docking, and dynamic studies were conducted over 50 ns and 100 ns on a panel of 39 natural phenolic acids. Rosmarinic acid (16) on the Mpro receptor (- 16.33 kcal/mol) and tannic acid (17) on the AAK1 receptor (- 17.15 kcal/mol) exhibited the best docking energy against both receptors. These favourable docking score values were found to be superior to those of the co-crystallized ligands. Preclinical and clinical research is required before using them simultaneously to halt the COVID-19 life cycle in a synergistic manner.

Topics & Concepts

PharmacophoreDocking (animal)Tannic acidRosmarinic acidSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)ProteaseChemistryCoronavirus disease 2019 (COVID-19)Caffeic acidAmino acid2019-20 coronavirus outbreakBiochemistryPharmacologyComputational biologyEnzymeBiologyVirologyMedicineAntioxidantOrganic chemistryDiseaseNursingPathologyInfectious disease (medical specialty)OutbreakComputational Drug Discovery MethodsSARS-CoV-2 and COVID-19 ResearchSynthesis and biological activity